2020
DOI: 10.1016/j.biomaterials.2020.120288
|View full text |Cite
|
Sign up to set email alerts
|

Construction and performance evaluation of Hep/silk-PLCL composite nanofiber small-caliber artificial blood vessel graft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
44
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 66 publications
(44 citation statements)
references
References 42 publications
0
44
0
Order By: Relevance
“…A purpose-built electrospinning device (SS-3556H, Ucalery, Beijing, China) with a double-nozzle conjugated electrospinning system was utilized to fabricate two-dimensional PLCL/SF scaffolds (2DS) as described previously [26]. PLCL and SF were dissolved in HFIP in a mass ratio of 8:2 at a total concentration of 10 % (w/v).…”
Section: Fabrication Of Two-dimensional Nano Ber Matsmentioning
confidence: 99%
“…A purpose-built electrospinning device (SS-3556H, Ucalery, Beijing, China) with a double-nozzle conjugated electrospinning system was utilized to fabricate two-dimensional PLCL/SF scaffolds (2DS) as described previously [26]. PLCL and SF were dissolved in HFIP in a mass ratio of 8:2 at a total concentration of 10 % (w/v).…”
Section: Fabrication Of Two-dimensional Nano Ber Matsmentioning
confidence: 99%
“…We have chosen the electrospinning technique for the dual loading of bioactive agents (ZnO and OEO). Poly ( l -lactide-co-caprolactone) (PLCL) is a synthetic polymer with excellent mechanical properties, biocompatibility as well as biodegradability [ 31 ]. Moreover, its potential as a drug carrier is also evident [ 32 , 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Among them, the PLLA blend with oligo-L-lactide-ε-caprolactone (OLCL) has an aliphatic chain, flexible character, and low melting temperature, which can improve the mechanical properties of PLLA [ 14 ]. Additionally, PLCL, with its great compliance matching and mechanical properties with natural blood vessels, has already been approved by the FDA for clinical applications [ 15 , 16 , 17 , 18 , 19 ]. The in vivo degraded acidic by-products of PLLA can contribute to a noninfectious inflammatory response in the body.…”
Section: Introductionmentioning
confidence: 99%